Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,586.9 | 76.43 | 3,80,702.48 | 753.53 | 1.01 | 5,566.68 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 5,914.5 | 67.17 | 1,56,907.86 | 557 | 0.51 | 2,357 | 561.08 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,573.2 | 60.81 | 1,20,890.67 | 551 | 0.17 | 2,567 | 224.34 |
Cipla Ltd CIPLA | 1,485.8 | 23.22 | 1,19,987.4 | 1,303.13 | 1.08 | 4,501.66 | 397.39 |
Mankind Pharma Ltd MANKIND | 2,467.1 | 56.23 | 1,01,774.78 | 412.76 | 0 | 2,541.36 | 354.71 |
This inspection, conducted from March 10 through March 13, 2025, was to evaluate compliance with the legal standards concerning bioequivalence studies.
The company saw its revenues increase by 1.5% YoY at ₹3,374 crore from ₹3,324 crore.
The serum contains liposomal azelaic acid, liposomal 4-butyl resorcinol, tranexamic acid, alpha arbutin, and niacinamide.
R&D expenses rose to ₹146.5 crore, making up 4.3% of total revenue, compared to ₹115.8 crore (3.4% of revenue) in the previous year.
This comes after competing private equity firms TPG Capital, Apax Partners, and KKR withdrew their original interest.
Alkem will conduct clinical trials of 'SON-080' in India, with Sonnet's support for global and local regulatory submissions.
According to sources, the floor price would be ₹5,616 per share, which is 3% lower than the current market price (CMP).
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.